A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began ...

A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

A large-scale study provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is just as effective as conventional radiotherapy for prostate cancer, without ...

Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity MIAMI, FLORIDA / ACCESS Newswire / March 19, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Since its European debut in 2021 [2], Radelumin has become a widely adopted tool for early detection, staging, and recurrence ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...